Literature DB >> 19268729

Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).

Francesca Cardarelli1, Antonio Bellasi, Fang-Shu Ou, Leslee J Shaw, Emir Veledar, Matthew T Roe, Douglas C Morris, Eric D Peterson, Lloyd W Klein, Paolo Raggi.   

Abstract

Age and chronic kidney disease are major risk factors for poor cardiovascular outcome; however, renal function is often estimated on the basis of serum creatinine levels, and advanced renal impairment may be hidden behind near normal creatinine levels. We assessed the impact of estimated glomerular filtration rate (GFR) on in-hospital mortality in young (<65 years old), old (65 to 84 years old), and very old (> or = 85 years old) patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction. The adjusted risk of death was calculated in 169,826 patients from the American College of Cardiology National Cardiovascular Data Registry undergoing primary PCI for acute myocardial infarction. Younger patients had fewer co-morbidities, higher estimated GFR, less frequent multivessel disease, and lower unadjusted mortality rates than older patients (p <0.0001 for all comparisons). However, the adjusted risk of in-hospital mortality for patients with severe renal insufficiency (estimated GFR <30 ml/min/1.73 m(2)) compared with those with normal renal function (estimated GFR > or = 60 ml/min/1.73 m(2)) was higher in young patients (adjusted odds ratio = 7.58, 95% confidence interval 6.18 to 9.29) than old (adjusted odds ratio = 4.75, 95% confidence interval 4.14 to 5.45) and very old patients (adjusted odds ratio = 3.50, confidence interval 2.50 to 4.89). In conclusion, severe renal insufficiency is associated with a greater risk of in-hospital mortality in young than old and very old patients after primary PCI. Risk stratification for patients with acute myocardial infarction should incorporate an assessment of renal function with estimated GFR values rather than absolute serum creatinine levels as done in the currently utilized risk scoring algorithms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268729     DOI: 10.1016/j.amjcard.2008.11.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.

Authors:  Patrik Htun; Suzanne Fateh-Moghadam; Christian Bischofs; Winston Banya; Karin Müller; Boris Bigalke; Konstantinos Stellos; Andreas E May; Marcus Flather; Meinrad Gawaz; Tobias Geisler
Journal:  J Am Soc Nephrol       Date:  2011-01-27       Impact factor: 10.121

Review 2.  Multivessel versus culprit-only revascularization: one time versus staged procedures for the ACS population.

Authors:  Pablo Codner; Ran Kornowski
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

3.  Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.

Authors:  Chih-Chao Yang; Hon-Kan Yip; Kuan-Hung Chen; Cheuk-Kwan Sun; Yen-Ta Chen; Han-Tan Chai; Pei-Hsun Sung; Hsin-Ju Chiang; Sheung-Fat Ko; Sheng-Ying Chung; Chih-Hung Chen; Kun-Chen Lin; Pao-Yuan Lin; Jiunn-Jye Sheu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

4.  Value of gated-SPECT MPI for ischemia-guided PCI of non-culprit vessels in STEMI patients with multivessel disease after primary PCI.

Authors:  Lawrence M Phillips; João V Vitola; Leslee J Shaw; Raffaele Giubbini; Ganesan Karthikeyan; Erick Alexanderson; Maurizio Dondi; Diana Paez; Amalia Peix
Journal:  J Nucl Cardiol       Date:  2018-08-01       Impact factor: 5.952

5.  Ischemic stroke: the impact of renal dysfunction on 1-year mortality.

Authors:  Tanja Hojs Fabjan; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

Review 6.  How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?

Authors:  Petr Widimsky; David R Holmes
Journal:  Eur Heart J       Date:  2010-11-30       Impact factor: 29.983

Review 7.  Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction.

Authors:  Mun K Hong
Journal:  Scientifica (Cairo)       Date:  2012-09-16

8.  Combined effects of admission serum creatinine concentration with age and gender on the prognostic significance of subjects with acute ST-elevation myocardial infarction in China.

Authors:  Zhao-Yang Li; Zhao-Hong Chen; Feng-Hui An; Li-Hua Li; Chang-Yan Guo; Yan Gu; Zhe Liu; Tie-Bing Zhu; Lian-Sheng Wang; Chun-Jian Li; Xiang-Qing Kong; Wen-Zhu Ma; Zhi-Jian Yang; En-Zhi Jia
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

9.  Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.

Authors:  Homam Ibrahim; Praneet K Sharma; David J Cohen; Gregg C Fonarow; Lisa A Kaltenbach; Mark B Effron; Marjorie E Zettler; Eric D Peterson; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

10.  An openEHR based approach to improve the semantic interoperability of clinical data registry.

Authors:  Lingtong Min; Qi Tian; Xudong Lu; Jiye An; Huilong Duan
Journal:  BMC Med Inform Decis Mak       Date:  2018-03-22       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.